Since reaching the clinic, magnetic resonance imaging (MRI) has become an irreplaceable radiological tool because of the macroscopic information it provides across almost all organs and soft tissues within the human body, all without the need for ionising radiation. The sensitivity of MR, however, is too low to take full advantage of the rich chemical information contained in the MR signal. Hyperpolarisation techniques have recently emerged as methods to overcome the sensitivity limitations by enhancing the MR signal by many orders of magnitude compared to the thermal equilibrium, enabling a new class of metabolic and molecular X-nuclei based MR tracers capable of reporting on metabolic processes at the cellular level. These hyperpolarised (HP) tracers have the potential to elucidate the complex metabolic processes of many organs and pathologies, with studies so far focusing on the fields of oncology and cardiology. This review presents an overview of hyperpolarisation techniques that appear most promising for clinical use today, such as dissolution dynamic nuclear polarisation (d-DNP), parahydrogeninduced hyperpolarisation (PHIP), Brute force hyperpolarisation and spin-exchange optical pumping (SEOP), before discussing methods for tracer detection, emerging metabolic tracers and applications and progress in preclinical and clinical application.
Introduction
Since reaching the clinic, magnetic resonance imaging (MRI) has become an irreplaceable radiological tool because of the macroscopic information it provides across almost all organs and soft tissues within the human body, all without the need for ionising radiation. In conventional MRI, the hydrogen nucleus (H-1)-or proton-is the most sensitive stable nucleus due to its high gyromagnetic ratio and abundance within the body. The sensitivity of MR, however, is too low to take full advantage of the rich chemical information contained in the MR signal. For instance, while nuclear magnetic resonance (NMR) spectroscopy is a workhorse in chemistry, in vivo MR spectroscopy (MRS) is limited to few clinical applications and a spatial, temporal and chemical resolution of cubic centimetres, minutes, and millimolar [1] . The promise of a non-invasive, spatially resolved chemical analysis, however, is immense. Hyperpolarisation techniques have recently emerged as methods to overcome these sensitivity limitations by enhancing the MR signal by many orders of magnitude compared to the thermal equilibrium [2] [3] [4] , and have enabled a new class of metabolic and molecular MR tracers capable of reporting on metabolic processes at the cellular level [5] [6] [7] .
Hyperpolarisation consists of generating a so-called hyperpolarised (HP) state, in which the population difference between nuclear energy levels is enhanced by several orders of magnitude (illustrated for spin ½ nuclei in Fig. 1 ). This population difference, or polarisation, is expressed as
, where N + and N − are the numbers of spins in the spin up and spin down populations respectively, and P is directly proportional to the MR signal. The HP state is a non-equilibrium condition of the spin system; therefore, the nuclear spins will relax back to their Boltzmann thermal equilibrium distribution over time with a corresponding loss of the HP signal enhancement. This decay rate is governed by the longitudinal (T 1 ) relaxation time, which varies from a few seconds to a few hours, depending on the nucleus, molecule and the surrounding environmental condition. Typically, for metabolic applications, the C-13 nucleus is hyperpolarised because of its favourable life time and chemical shift dispersion compared to hydrogen.
In a typical HP metabolic imaging experiment, a metabolic substrate isotopically enriched with a magnetically active nucleus, usually C-13, is hyperpolarised and rapidly injected in vivo to track metabolism in real time (Fig. 2) . In vivo, the HP nucleus is rapidly exchanged between the substrate and its metabolic products during enzymemediated metabolic reactions, and by means of chemical shift resolution and the large signal enhancement, these metabolites can be distinguished. To maximise the signal available for the experiment, the hyperpolariser should be close to the MR scanner, and transfer rapid [11] [12] [13] [14] .
HP tracers have rapidly become a promising molecular imaging tool for non-invasive in vivo metabolic studies due to the unique metabolic insights they provide. Ionising radiation, like in very sensitive positron emission tomography (PET), is not required [6] . The goal of this review is to present an overview of HP molecular and metabolic imaging, tracer production, detection and progress in preclinical and clinical application.
Hyperpolarisation Technology
Here, we describe dissolution dynamic nuclear polarisation (d-DNP) [2, 6, 7] , para-hydrogen (pH 2 )-induced polarisation (PHIP) [4, 15] , Brute force hyperpolarisation [16] and spinexchange optical pumping (SEOP) [3, 17, 18] .
Dissolution Dynamic Nuclear Polarisation
While DNP history started already in the 1950s [19] , the recent interest in solid-state NMR and dissolution-DNP experiments was enabled by the development of improved microwave technologies and more efficient mono-and biradicals [20] . The potential of DNP in modern MRI and solid-state NMR was demonstrated with d-DNP by Golman and co-workers [2] , and by low-temperature magic angle spinning DNP (MAS-DNP) by Griffin and co-workers [21] . The first d-DNP setup for preclinical studies [2] was at 3.35 T with the ready availability of microwave sources at 94 GHz with maximum powers in the 100-400 mW range, while nowadays, commercial polarizers operate at 5 T (SPINlab, General Electrics). At a typical temperature of1
.4 K, DNP takes place transferring the high electronic polarisation of a paramagnetic agent-i.e., unpaired electrons added in the form of radical molecules at mM concentrations-to magnetically active nuclei in the sample, such as 13 C (Fig. 3a) , irradiating the EPR lineshape under static conditions [22] .
At this time, three distinct mechanisms are usually involved to describe polarisation transfer in DNP, whose contribution depends on the EPR linewidths of the radical in comparison to the nuclear Larmor frequency, among other factors. In particular, the solid effect deals with a two-spin system by taking into account the interaction between the electronic and the nuclear spin; the cross effect accounts for the polarisation transfer from two coupled electrons, whose resonance frequency (ω 0S1,2 ) is separated by the Larmor frequency of the nuclei (ω 0I ) that are to be polarised, ω 0S1 − ω 0S2 = ω 0I [23] . The thermal mixing mechanism exploits thermodynamic concepts and describes the polarisation transfer in terms of heat exchange between different reservoirs [24] [25] [26] [27] .
The sample formulation and radical stability affects the polarisation performance: the unpaired electrons should be homogenously dispersed (oligomers and clustering are detrimental) in the sample matrix and a suitable glassy agent (such as dimethylsulfoxide, glycerol) is usually added to the formulation. The presence of small amounts of lanthanide chelates, such as Gd 3+ , can also further enhance the polarisation [28] . A fast dissolution occurs by rapid melting of the sample through direct contact with a superheated (180-200°C) and pressurised (e.g., 10 bar helium) aqueous medium to produce solutions at temperatures and pH values suitable for injection in vivo, while preserving most of the hyperpolarisation [2] .
In more recent years, the interest in hyperpolarising water (i.e., of protons diluted in heavy water) led to promising results: polarisation, dissolution and radical extraction for water/DMSO-d6 samples were shown to provide a polarisation and T 1 suitable for in vivo MR perfusion imaging [29] [30] [31] . Many efforts are currently underway to improve the polarisation efficiency for H-1 and C-13 nuclei with the synthesis of new radicals and better design of d-DNP is currently expensive because of its need for dedicated instrumentation including a superconducting magnet, and requires the addition of a radical (that is subsequently removed before injection into patients [30] ). Recently, however, d-DNP of pyruvate was achieved using Fig. 1 Schematic view of spin-½ nuclei populating two energy levels in a magnetic field at thermal equilibrium (left) and after hyperpolarisation (right). At thermal equilibrium, both energy levels are populated according to the Boltzmann distribution. At clinical field strengths, thermal energy dominates the population (left), and both energy levels are almost equally populated. Only the population difference contributes effectively to the MR signal, indicated in red. The goal of hyperpolarisation is to increase the population of one energy level so that the MRI signal is also increased (right). Reproduced with permission [8, 9]. Fig. 2 Schematic view of a typical hyperpolarisation experiment. After the production of the HP tracer in the polariser, the solution is injected into the bloodstream and distributed in vivo. Labelled [1- 13 C]acetate is shown as an example and undergoes metabolism to [1- 
Parahydrogen Induced Polarisation
Parahydrogen-induced polarisation (PHIP) exploits the pure but MR-invisible spin singlet order of parahydrogen (pH 2 ). pH 2 denotes one of four combinations of the nuclear spins of the dihydrogen molecule (one para, three ortho). The parafraction of hydrogen gas is relatively easily to enrich to1 00 % by catalytic conversion at low temperature,~23 K. If stored appropriately, in the absence of the catalyst (e.g., in an aluminium flask with little paramagnetic impurities), the lifetime of the para-state is several days to weeks [54] and is thus Bspin order on demand^.
This spin order is transferred to a target molecule, either by pair-wise addition (hydrogenation, PASADENA [4, 55, 56] Recently, high C-13 HP of pyruvate by pH 2 was demonstrated and used to monitor metabolism [83] .
Besides the limitation of suitable tracers, the removal of the hydrogenation catalyst may be the most significant challenge of PHIP methods. Although promising approaches using either heterogeneous hydrogenation [84, 85] [1- 13 C]pyruvate was injected into mice and 3.5 ± 0.5 % [1- 13 C]pyruvate polarisation was detected at the heart and in vivo metabolism was observed [83] . HP [1- 13 C]hydroxyenthyl-propionate was polarised within an MRI scanner using only the scanner hardware, and the tracer's in vivo distribution was measured 10-15 s after production and injection [90] . SABRE has been achieved in numerous aqueous solutions for 1 
Brute Force Hyperpolarisation
The simplest approach to achieve a high sample thermal equilibrium polarisation is to apply strong magnetic fields and low temperatures. This method was first used for the HP of noble gases and D 2 gas [98, 99] and later to obtain a liquid, aqueous solution containing metabolic tracers [16] . For both cases, the sample is frozen during HP and melted or evaporated (in the case of HP gases) before usage. He-3 gas, for instance, is evaporated at 6-7 K and extraction can be done much faster than the longitudinal relaxation time of the He-3 liquid of T 1 = 300 s (at 1 bar pressure) [98] . Note that Xe-129 has a much higher boiling point of T ≈ 165 K. In the case of liquid metabolic tracers, a frozen sample is ejected from the polariser after HP and quickly dissolved in warm H 2 O. In the only published examples, P G 1 % is achieved for pyruvate at 14 T and~2. . These long lifetimes may enable the off-site production and delivery of HP tracers, similar to PET-tracers-a concept that in principle could be applied to any polarisation method free of in-sample relaxation agents.
The production of liquid, metabolic HP tracers using the brute force method is relatively new and has yet to be fully explored. C-13 enhancement factors of 9 1500 and~150 have been demonstrated at 1 and 9.4 T [100] respectively, which is still too low for biomedical applications. Higher polarisation levels could be achieved at even lower temperatures and higher fields but this poses technical challenges and increases the required time for HP.
Spin-Exchange Optical Pumping
In spin-exchange optical pumping, circularly polarised light is used to selectively optically pump (typically) rubidium (Rb) electrons, generating a highly spin polarised Rb gas. These atoms subsequently transfer spin polarisation through spin-exchange collisions with noble gas nuclei, such as Xe-129 [3] The polarisation of HP agents relaxes back to thermal equilibrium very rapidly, losing the entire signal enhancement endowed by the hyperpolarisation process. Depending on the orientation of the magnetisation, the loss is governed by T 1 or T 2 . Imaging speed and efficient use of the finite magnetisation are therefore critical factors. In general, rfheavy sequences or those with high flip angles should be avoided because every excitation used during the course of a pulse sequence will draw on the finite pool of HP magnetisation-although sequences that continually refocus transverse magnetisation using rf pulses, such as steady-state free precision sequences [123] , can mitigate this effect. Additionally, spectroscopically selective pulses can spare magnetisation of the injected tracer and increase SNR on metabolites of interest [124] .
To obtain information on enzyme-catalysed metabolism, dynamic, spectrally resolved data (such as those in Fig. 2) , are analysed to yield values of the conversion rate constants [125] . In the simplest but most sensitive implementation, the data is acquired by pulse-acquisition experiments with a local coil. For improved spatial resolution, specialised acquisition methods such as chemical shift imaging (CSI) are needed (Fig. 4, 6a) .
Imaging within in vivo experiments is usually done using single-shot acquisitions: echo-planar spectroscopic imaging (EPSI) [129] [130] [131] [132] or center-out k-space encoding (spiral read-out) can be customised for fast k-space coverage. In this case, spiral CSI (SPCSI) ( [1- 13 C]Pyruvate is the most commonly used molecule in vivo because it has a central role in cell metabolism; at the crossroads of anaerobic and aerobic metabolism, it is either exchanged into lactate or forms Acetyl-CoA and carbon dioxide [140] . The metabolic conversion of pyruvate into its main downstream metabolites lactate, bicarbonate and alanine (Fig. 4) can be tracked in vivo and in real-time to investigate the flux of key enzymes such as lactate dehydrogenase (LDH), pyruvate dehydrogenase (PDH) or alanine transaminase (ALT), in different metabolic pathways and pathological conditions [141] . HP-pyruvate has been mainly used as a probe of glycolytic metabolism in cancer and in the heart, as well as in other tissues, such as the brain and liver. This section describes investigations that have been conducted with [1- 13 C]pyruvate and other emerging substrates.
Biomedical Applications of Hyperpolarised Metabolic and Molecular Tracers

Probing Lactate Dehydrogenase
Lactate dehydrogenase (LDH) catalyses the reversible metabolic conversion of pyruvate into lactate in the cytosol. Due to the Warburg Effect, cancer cells show increased glycolytic activity and glucose uptake in aerobic conditions, resulting in the production of lactate. Intravenous administration of HP [1- 13 C]pyruvate results in an enhanced spectroscopic signal of [1- 13 C]lactate in tumours due to enzymatic exchange via LDH that can be correlated both with tumour staging [5, 124, 142] and with treatment response [45, 143] .
LDH-catalysed metabolic conversion of [1-13 C]pyruvate into [1- 13 C]lactate has also been investigated in the field of cardiology since both lactate pool size and production depend on the metabolic status of the heart. Due to the onset of acidosis and to the shift towards anaerobic metabolism, the lactate concentration is increased early after ischaemia, resulting in a larger lactate pool. An increase in LDH flux has been detected in vitro in the isolated rat heart [144] and in pigs after ischaemia-reperfusion injury [145] . A significant increase in [1- 13 C]lactate was also detected in pigs subjected to cardiac inotropic stress induced by intravenous dobutamine administration [146] , suggesting an increase of the flux through LDH in conditions of higher energy demand. Conversely, in a porcine model of dilated cardiomyopathy induced by chronic rapid right ventricular pacing, no variation was detected in the [1- 13 C]lactate/[1-13 C]pyruvate signal ratio, corresponding to an unchanged LDH flux [147] .
It should be noted, too, that lactate and phospholactate were polarised by DNP [148] and PHIP [149] , respectively. Because the lactate pool is much larger in vivo than the pyruvate pool, only little signal of hyperpolarised pyruvate was observed in these experiments. A deuterium label was used to facilitate the analysis of the data.
Probing Pyruvate Dehydrogenase
HP [1- 13 C]pyruvate can also be used to probe citric acid cycle carbon flux. In vivo metabolic conversion into [1-13 C]bicarbonate provides information about the activity/flux of the multienzyme complex pyruvate dehydrogenase (PDH) that regulates the irreversible decarboxylation of pyruvate to acetyl-CoA (ACoA), the energetic fuel of the Krebs cycle (Fig. 4) . The PDH complex has a key role in the balance between glucose and FA oxidation, in competition for the ACoA supply in cardiac cells [150] . Therefore, the flux through PDH should be highly flexible in response to different substrate availability in order to meet the haemodynamic demand in different physiological states or pathological conditions. Merritt et al. first showed that the rate of appearance of HP H 13 CO 3 − and HP 13 CO 2 , after injection of HP [1- 13 C]pyruvate in the isolated rat heart could be directly related to the flux through PDH [151] . The enzymatic flux through PDH has also been investigated in vivo, in small and large animal models, by detecting the metabolic conversion of HP [1- 13 C]pyruvate into [ 
Probing Alanine Transaminase
Pyruvate can be also generated through the catabolism of various amino acids, including alanine, one of the major gluconeogenic precursors: pyruvate and alanine are the central substrates in the alanine cycle, a recycling and scavenging pathway linking muscle and liver metabolism. explore the transamination activity and alanine pool size. This is relevant for liver disease [159] because liver is a primary site of ALT enzyme activity.
A few studies have investigated the reversible nature of the ALT catalysed conversion and detected [1- 13 C]pyruvate spectroscopic signal after the injection of HP [1- 13 C]alanine [160] . In the heart, the exchange rate of the 13 C label from [1- 13 C]pyruvate to [1-13 C]alanine was increased in hypertrophy in a rat model of hyperthyroidism [161] and in conditions of increased cardiac workload in pigs and in rats, after dobutamine administration [146, 162] .
Investigation of Krebs Cycle Intermediates
Further characterisation of PDH flux is possible by injection of HP [2- 13 C]pyruvate to investigate the real-time incorporation of pyruvate-derived ACoA into the Krebs cycle. In this case, the labelling in the C2 position is exchanged with ACoA during the PDH mediated conversion of [2- 13 C]pyruvate, thus allowing the tracking of Krebs cycle intermediates such as citrate and glutamate. The observation of the [2-13 C]pyruvate metabolic products is linked to the contribution of pyruvate incorporation into the TCA cycle and allows for exploration of mitochondrial substrate selection.
The injection of HP [1,2-13 C]pyruvate was also performed in pigs to allow simultaneous in vivo investigation of PDH flux, Krebs cycle flux and pH [163] . An enhancement of PDH flux and incorporation into the Krebs cycle intermediates was also found in the spontaneously hypertensive rat heart after injection of HP [1- 13 C]pyruvate and [2-13 C]pyruvate, demonstrating a switch of cardiac metabolism from fatty acids towards glucose oxidation [164] . In contrast, early stage heart failure resulted in a decrease of pyruvate flux through PDH and subsequent incorporation into the Krebs cycle [165] [166] [167] . The [1- 13 C]acetylcarnitine (ALCAR) produced from the [2- 13 C]pyruvate-derived ACoA, through a metabolic reaction catalysed by the enzyme carnitine acetyltransferase (CAT), can be also detected. In a study performed in rats using HP [2-13 C]pyruvate, the authors describe a dynamic cycling mechanism of [2- 13 C]pyruvate-derived ACoA into the ALCAR pool (through the enzyme CAT) before entering the Krebs cycle, thus underlining a 'fine-tuning' mechanism of CAT-mediated disposal of ACoA [166] .
In vivo Fatty Acid Metabolism HP 13 C-MRI has been used to probe in vivo fatty acid (FA) metabolism. The metabolic fate of FA inside the cell is highly regulated: once taken up by the cytosol, FA are esterified to fatty acyl-CoA and converted to long-chain ALCAR, which is located in the outer mitochondrial membrane, prior to entering the mitochondria. Acyl-CoA finally undergoes to β-oxidation to generate ACoA (in competition with glucose-derived ACoA) and the reducing equivalents NADH and FADH 2 .
[1-13 C]Acetate was among the first FA metabolism HP probes. Recalling the β-oxidation theory of fat metabolism, [1- 13 C]acetic acid attracted great interest as a probable intermediary metabolite in fat oxidation: indeed, FA are the To the left: schematic representation of the metabolic pathways involving pyruvate: the reduction into lactate, the transamination into alanine, and the conversion into bicarbonate can be tracked using hyperpolarised [1- 13 C]pyruvate, while the conversion into acetyl CoA and subsequent incorporation into the Krebs cycle can be studied with hyperpolarised [2-13 C]pyruvate (below). To the right, a schematic representation of the highly regulated metabolic pathway involving free fatty acid (FFA) is shown. In the figure, the enzymes catalysing the different metabolic reactions are highlighted in light green. (ii) shows a pH map of the same animal calculated from the ratio of the H 13 CO 3 -(iii) and 13 CO 2 (iv) voxel intensities in 13 C chemical shift images acquired~10 s after intravenous injection of~100 mM hyperpolarised H 13 CO 3 -. pH is shown to be reduced in the tumour region [127] . c Imaging redox status in murine lymphoma models:
13 C MR spectra acquired from a 6-mm tumour slice following injection of 30 mM [1- 13 C]ascorbic acid (i) and [ 
Redox Probes
HP probes have been used to detect redox reactions: both the reduced and oxidised form of vitamin C, i.e., [1- 13 C]ascorbic acid ( 13 C-AA) and [1-13 C]dehydroascorbic acid ( 13 C-DHA) have been tested. Several diseases are characterised by an altered production of reactive oxygen species (ROS), leading to a dysregulation of the cellular redox potential and to an increased tissue oxidative stress. An enhanced oxidative stress is considered a hallmark of different cancer phenotypes [180]; moreover, high levels of oxidative stress can be found in infectious diseases, chronic inflammation and diabetes [181] .
Studies with HP 13 C-DHA have been carried out to investigate the status of oxidative stress of a tissue through the observation of its reducing capacity, reflected by the local concentration of reducing agents (especially glutathione). Preliminary studies have been conducted in tumour cell cultures and in small animal models. In these studies, the conversion of 13 C-DHA into 13 C-AA can be observed and semi-quantitatively assessed through the measured VitC / (DHA + VitC) ratio. This parameter, which provides indications of the tissue redox capacity, has been mainly related to the glutathione tissue concentration, and to a lesser extent to the glucose transporter (in particular to GLUT4) [182] , the rate of NADPH production, the flux through the cytosolic pentose phosphate pathway [183] and the expression of the enzyme NAPDH oxidase 4 (Nox4) [184] .
[ 13 C]AA has also been hyperpolarised to track the in vivo oxidation into [
13 C]DHA and to provide direct evidence of the tissue redox status (Fig. 6c) (Fig. 7) [188, 189] , cell surface glycans [190] , a number of receptors such as integrin (known to be upregulated in some cancers) [191] , EGFR [192] and transferrin [193] -even cancer cells [121, 192] . Recently, important in vitro and in vivo demonstrations have included the in vitro use of MS2 viral capsids as macromolecular biosensor hosts (Fig. 7b) for lymphoma cell detection at picomolar concentrations [121], the first in vivo detection of a Xe-129 biosensor: (non-functionalised) cucurbit[6]uril (CB6) [122] , and the in vitro use of a fluorescent biosensor for mitochondria detection [194] .
In the Xe-129 biosensor concept, many of Xe-129's remarkable properties are exploited to create a sensitive biomolecular spy: HP Xe-129 has a distinct resonance in the gas phase which is manifested as a single peak in an NMR spectrum. When free Xe-129 exchanges with a functionalised biosensor population, two further distinct peaks will appear in the spectrum, originating from its respective exchange with target-bound and unbound biosensor populations. These further peaks result from the exquisite chemical shift sensitivity of Xe-129 to its environment, and provide a means to distinguish between the populations. Extremely low concentrations of the target-bound, functionalised biosensors can be detected using Hyper-CEST, which takes the existing concept of CEST-detection of the saturation of a dilute spin pool A (the target-bound functionalised cages) via the monitoring of the depletion of an exchange-coupled and significantly larger spin pool B (free HP Xe-129)-but combines it with a HP spin pool B, thereby substantially enhancing the sensitivity.
Diseases are complex in nature, often presenting with many unique biomarkers simultaneously. Xenon biosensors may ultimately offer unique and powerful diagnostic opportunities due to the potential for the deployment of multiple biosensors at the same time [195] , each uniquely targeting different biomarkers of the same disease simultaneously (and potentially detected simultaneously)-a concept known a multiplexing [107, 186, 195] . However, translation to in vivo imaging is faced by a number of challenges including RF tissue heating, delivery of both HP Xe-129 and the biosensors to the site of interest, and unknowns regarding biocompatibility of some sensors [196] .
Human Applications
Hyperpolarised Tracers for Metabolic Imaging
Hyperpolarisation has been translated into humans using d-DNP HP 13 C-pyruvate as the injected substrate. The first study by Nelson et al. used a prototype hyperpolariser and demonstrated the feasibility of the method to reveal real-time lactate formation in prostate cancer [46] . There is initial evidence from this study that metabolic imaging may detect tumours that are occult on conventional imaging; current studies are addressing whether the method can better stratify tumour aggressiveness based on lactate formation, as has been demonstrated in animal models [142] . There is preliminary evidence demonstrating that HP [1- 13 C]lactate labelling may decrease following therapy in prostate cancer (Fig. 8a) [45] which builds on similar pre-clinical data in several tumour models [143] . More recently, the metabolism of HP [1- 13 C]pyruvate has also been imaged in glioma [47] . Therefore, the technique may have a role in the stratification of tumour aggressiveness and the early detection of treatment response [197] .
Given the high metabolic activity of the heart, HP [ 13 C]pyruvate has also shown promise in probing cardiac disease. A single human study has been published to date showing the formation of both [1- 13 C]lactate and [1 13 C]bicarbonate in the normal human heart following the injection of [1- 13 C]pyruvate (Fig. 8b) [48]. Ongoing studies are using the technique to probe alterations in cardiac metabolism in human disease.
Hyperpolarised Gas Imaging
Imaging of the lungs with HP gases offers the possibility of detecting regional variations in ventilation and lung function which as early features of pulmonary disease. The majority of pulmonary imaging with HP gases has been undertaken using He-3 given its strong MR signal, but more recently, there has been an increase in the use of Xe-129 to assess lung ventilation, microstructure and regional gas exchange [198] . This has been driven by the decreased availability of He-3 and improvements in Xe-129 gas technology. HP gas imaging has been used to assess healthy subjects, smokers and patients with asthma and chronic obstructive pulmonary disease (COPD) [199] [200] [201] . In particular, the high level of regional variability in patients with COPD can be used to monitor early disease and as a biomarker of response to therapy [202] , for example in the context of clinical trials. While HP gas MRI is not used as a routine clinical tool, it has the potential to be used in stratified patient populations to assist clinical decision making.
Conclusion
HP imaging technologies offer great potential to provide important new insights into metabolic changes that occur in human disease and following treatment. However, there are many challenges in translating these methods into humans, including the need for dedicated hardware and a requirement for significant technical expertise across a broad range of disciplines such as physics, chemistry, biology and medicine. Importantly, the need to produce agents suitable for human use may require investment in dedicated pharmacy Fig. 8 Top: Proton T 2 -weighted (T2W), apparent diffusion coefficient (ADC), and T 2 W images with an overlaid pyruvate-tolactate metabolic flux (kPL) image, with corresponding HP 13 C spectral array (SA) for a 52-year-old prostate cancer patient (a) before therapy and (b) 6 weeks after initiation of androgen ablation and chemotherapy. Before treatment, the prostate cancer can be clearly seen (red arrows) as a reduction in signal on the T 2 W and ADC images, and increased HP lactate and associated kPL flux on HP 13 C MRI. After therapy, there was a significant reduction in HP lactate and kPL to normal levels, with only a modest treatment effect on prostate volume and ADC [45] . Bottom: Representative 13 C images overlaid on grayscale anatomical images in a mid-left ventricle (LV) slice from two healthy volunteers (a-c) and (d-f), respectively. [1- 13 C]pyruvate is visible mainly in the blood pool within the cardiac chambers (a, d). facilities and there significant regulatory hurdles that need to be overcome which can be very specific to individual countries. Key to the successful translation of the technique will be the development of methods to accurately and reproducibly quantify the metabolism of HP substrates in vivo [125] . Despite these challenges, HP MRI has been used in a number of different clinical settings including oncology, cardiology and respiratory medicine. dramatically 
